𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Subtype and genotypic resistance analysis of HIV-1 infected patients in Austria

✍ Scribed by Barbara Falkensammer; Martin Doerler; Harald H. Kessler; Elisabeth Puchhammer-Stoeckl; Walter Parson; Christina Duftner; Manfred P. Dierich; Heribert Stoiber

Publisher
Springer Vienna
Year
2007
Tongue
English
Weight
100 KB
Volume
119
Category
Article
ISSN
0043-5325

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term monitoring of genotypic and ph
Long-term monitoring of genotypic and phenotypic resistance to T20 in treated patients infected with HIV-1
✍ L. Pérez-Alvarez; R. Carmona; A. Ocampo; A. Asorey; C. Miralles; S. Pérez de Cas 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 388 KB

The aim of this study was to investigate the susceptibility to T20 and the dynamics of amino acid changes in HR1 and HR2 of gp41 of HIV-1 obtained from plasma, peripheral blood mononuclear cells (PBMC), and primary isolates (PI) in four highly antiretroviral-experienced patients. These patients rece

Antiretroviral genotypic resistance in p
Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART
✍ Annalisa Saracino; Nicola Gianotti; Marianna Marangi; Donatella C. Cibelli; Andr 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB

## Abstract The extent to which HIV‐1 proviral DNA mutations cause clinically relevant antiretroviral resistance is still controversial. Paired plasma HIV‐1 RNA and whole blood DNA were compared in patients failing HAART to investigate if the additional knowledge of archived mutations could improve

Evolution of genotypic and phenotypic re
Evolution of genotypic and phenotypic resistance to Enfuvirtide in HIV-infected patients experiencing prolonged virologic failure
✍ Eva Poveda; Berta Rodés; Jean-Louis Labernardière; José Miguel Benito; Carlos To 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB

## Abstract Four heavily antiretroviral‐experienced HIV‐infected patients had significant plasma HIV‐RNA reductions (>1 log) after beginning an Enfuvirtide (ENF)‐based rescue regimen. However, all had viral rebound shortly thereafter, sustaining high levels of plasma viremia over 80 weeks. These pa

Lopinavir/ritonavir resistance in patien
Lopinavir/ritonavir resistance in patients infected with HIV-1: two divergent resistance pathways?
✍ Karen Champenois; Agathe Baras; Philippe Choisy; Faiza Ajana; Hughes Melliez; La 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 1 views

## Abstract The HIV‐1 protease L76V mutation has been described recently as conferring high‐level resistance to lopinavir/ritonavir (LPV/r). The aim was to identify the factors and particularly protease mutations associated with the presence of L76V in treatment‐experienced patients infected with H

Epstein Barr virus genotypes and LMP-1 v
Epstein Barr virus genotypes and LMP-1 variants in HIV-infected patients
✍ Rita Mariel Correa; María Dolores Fellner; Karina Durand; Liliana Redini; Virgin 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB

## Abstract Two Epstein Barr virus (EBV) genotypes: EBV‐1 and EBV‐2 have been described. A 30‐bp deletion in latent membrane protein‐1 gene (del‐LMP‐1) has been identified in various pathologies. The aim of this study was to determine EBV genotypes and 30‐bp deletion frequency in HIV‐infected patie

Comparative performance of the Amplicor
Comparative performance of the Amplicor HIV-1 monitor assay versus NucliSens EasyQ in HIV subtype C-infected patients
✍ Bat Sheva Gottesman; Zehava Grossman; Margalit Lorber; Itzchak Levi; Pnina Shitr 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

In facing global programs for treating HIVinfected patients in the developing countries, there is a real need for viral load assays that are accurate for the local subtypes. The present study was designed to evaluate viral load measurements using the newer version of the NASBA assay in subtype C-inf